United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 5 minute read Healthcare Industry News HealthEZ introduces EZrx to cut pharmacy costs by 50% for self-funded employer plans Discover how HealthEZ’s new EZrx platform aims to slash pharmacy benefit costs by up to 50% with smarter sourcing and clinical review innovation. byPallavi MadhirajuMay 21, 2025